Director dealings: Outgoing Carclo CEO lowers stake

6th Feb 2019 16:03

(Sharecast News) - Outgoing Carclo chief executive Chris Malley disposed of 100,000 ordinary shares in the technical plastics supplier on Wednesday.Malley, who joined Carclo back in 1999, sold the shares at an average price of 46.50p each, for a total value of £46,500.Carclo told investors back in January that, after being very successful in winning low-volume and mid-volume automotive lighting programmes, the group's Wipac subsidiary had struggled to meet customer requirements, an issue that worsened in the third quarter after demand grew."The consequences of this have been significant with adverse operational variances, expedited freight deliveries and poor customer service leading to additional unplanned costs and, very recently, to delays in new programme awards and the profit recognition thereon," said a statement from Carclo.In order to combat the issues facing Wipac, Malley resigned and left the board to take on the role of LED Technologies divisional chief executive with immediate effect.As of 1600 GMT, Carclo shares had tumbled 6.96% to 44.66p.Top Director BuysGlaxosmithkline (GSK)Director name: Glimcher,Laurie Amount purchased: 2,800 @ 1,963.50pValue: £54,973.13Glaxosmithkline (GSK)Director name: Hampton,Philip RAmount purchased: 2,926 @ 1,495.00pValue: £43,749.99Glaxosmithkline (GSK)Director name: Elsenhans,LynnAmount purchased: 2,100 @ 1,963.50pValue: £41,229.85Oxford Biomedica (OXB)Director name: Heath,AndrewAmount purchased: 2,820 @ 704.00pValue: £19,852.80Glaxosmithkline (GSK)Director name: Lewent,JudyAmount purchased: 941 @ 1,963.50pValue: £18,482.35Ingenta (ING)Director name: Royde ,Max Amount purchased: 25,000 @ 73.00pValue: £18,250.00Glaxosmithkline (GSK)Director name: Goodman,Jesse Amount purchased: 845 @ 1,963.50pValue: £16,586.71Aberdeen Emerging Markets Investment Company (AEMC)Director name: Green,Helen FAmount purchased: 1,800 @ 548.88pValue: £9,879.84Dunedin Enterprise Investment Trust (DNE)Director name: Lane,Angela Amount purchased: 2,473 @ 364.56pValue: £9,015.49Glaxosmithkline (GSK)Director name: Rohner,UrsAmount purchased: 481 @ 1,495.00pValue: £7,187.50Glaxosmithkline (GSK)Director name: Banga,Manvinder SinghAmount purchased: 481 @ 1,495.00pValue: £7,187.50Glaxosmithkline (GSK)Director name: Cox,VivienneAmount purchased: 355 @ 1,495.00pValue: £5,312.50Rathbone Brothers (RAT)Director name: Stockton,PaulAmount purchased: 7 @ 2,304.00pValue: £161.28Rathbone Brothers (RAT)Director name: Howell ,Philip Amount purchased: 7 @ 2,304.00pValue: £161.28Rathbone Brothers (RAT)Director name: Butcher,AndrewAmount purchased: 7 @ 2,304.00pValue: £161.28Stagecoach Group (SGC)Director name: Griffiths,Martin AndrewAmount purchased: 97 @ 155.17pValue: £150.51Stagecoach Group (SGC)Director name: Paterson,Ross Amount purchased: 97 @ 155.17pValue: £150.51Close Brothers Group (CBG)Director name: Prebensen,PrebenAmount purchased: 10 @ 1,451.00pValue: £145.10Primary Health Properties (PHP)Director name: Hyman,Harry AbrahamAmount purchased: 84 @ 116.40pValue: £97.78Primary Health Properties (PHP)Director name: Hyman,Harry AbrahamAmount purchased: 84 @ 116.40pValue: £97.78Top Director SellsCarclo (CAR)Director name: Malley ,Chris Amount sold: 100,000 @ 46.50pValue: £46,500.00Oxford Biomedica (OXB)Director name: Heath,AndrewAmount sold: 2,832 @ 703.00pValue: £19,908.96